Literature DB >> 23848828

Diversification of NAD biological role: the importance of location.

Michele Di Stefano1, Laura Conforti.   

Abstract

Over 100 years after its first discovery, several new aspects of the biology of the redox co-factor NAD are rapidly emerging. NAD, as well as its precursors, its derivatives, and its metabolic enzymes, have been recently shown to play a determinant role in a variety of biological functions, from the classical role in oxidative phosphorylation and redox reactions to a role in regulation of gene transcription, lifespan and cell death, from a role in neurotransmission to a role in axon degeneration, and from a function in regulation of glucose homeostasis to that of control of circadian rhythm. It is also becoming clear that this variety of specialized functions is regulated by the fine subcellular localization of NAD, its related nucleotides and its metabolic enzymatic machinery. Here we describe the known NAD biosynthetic and catabolic pathways, and review evidence supporting a specialized role for NAD metabolism in a subcellular compartment-dependent manner.
© 2013 FEBS.

Entities:  

Keywords:  ARTs; NAD; NAD biological functions; NAD biosynthesis; NAD degradation; NAMPT; NMNAT; Sirtuins; subcellular compartments

Mesh:

Substances:

Year:  2013        PMID: 23848828     DOI: 10.1111/febs.12433

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  32 in total

1.  Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence.

Authors:  Marshall Lukacs; Jonathan Gilley; Yi Zhu; Giuseppe Orsomando; Carlo Angeletti; Jiaqi Liu; Xiuna Yang; Joun Park; Robert J Hopkin; Michael P Coleman; R Grace Zhai; Rolf W Stottmann
Journal:  Exp Neurol       Date:  2019-05-25       Impact factor: 5.330

2.  Nuclear transport of nicotinamide phosphoribosyltransferase is cell cycle-dependent in mammalian cells, and its inhibition slows cell growth.

Authors:  Petr Svoboda; Edita Krizova; Sarka Sestakova; Kamila Vapenkova; Zdenek Knejzlik; Silvie Rimpelova; Diana Rayova; Nikol Volfova; Ivana Krizova; Michaela Rumlova; David Sykora; Rene Kizek; Martin Haluzik; Vaclav Zidek; Jarmila Zidkova; Vojtech Skop
Journal:  J Biol Chem       Date:  2019-04-11       Impact factor: 5.157

3.  Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models.

Authors:  Benjamin A Harlan; Kelby M Killoy; Mariana Pehar; Liping Liu; Johan Auwerx; Marcelo R Vargas
Journal:  Exp Neurol       Date:  2020-01-31       Impact factor: 5.330

4.  Heterologous expression of mitochondrial nicotinamide adenine dinucleotide transporter (Ndt1) from Aspergillus fumigatus rescues impaired growth in Δndt1Δndt2 Saccharomyces cerevisiae strain.

Authors:  Laís de Lourdes de Lima Balico; Emerson de Souza Santos; Silveli Suzuki-Hatano; Lucas Oliveira Sousa; Ana Elisa Caleiro Seixas Azzolini; Yara Maria Lucisano-Valim; Taisa Magnani Dinamarco; Vinicius Kannen; Sérgio Akira Uyemura
Journal:  J Bioenerg Biomembr       Date:  2017-11-11       Impact factor: 2.945

Review 5.  Role of mitochondria in diabetic peripheral neuropathy: Influencing the NAD+-dependent SIRT1-PGC-1α-TFAM pathway.

Authors:  Krish Chandrasekaran; Muragundla Anjaneyulu; Joungil Choi; Pranith Kumar; Mohammad Salimian; Cheng-Ying Ho; James W Russell
Journal:  Int Rev Neurobiol       Date:  2019-06-08       Impact factor: 3.230

6.  Enhanced SIRT6 activity abrogates the neurotoxic phenotype of astrocytes expressing ALS-linked mutant SOD1.

Authors:  Benjamin A Harlan; Mariana Pehar; Kelby M Killoy; Marcelo R Vargas
Journal:  FASEB J       Date:  2019-03-06       Impact factor: 5.191

7.  Omics Integration for Mitochondria Systems Biology.

Authors:  Xin Hu; Young-Mi Go; Dean P Jones
Journal:  Antioxid Redox Signal       Date:  2020-02-03       Impact factor: 8.401

Review 8.  Exploring NAD+ metabolism in host-pathogen interactions.

Authors:  Inês Mesquita; Patrícia Varela; Ana Belinha; Joana Gaifem; Mireille Laforge; Baptiste Vergnes; Jérôme Estaquier; Ricardo Silvestre
Journal:  Cell Mol Life Sci       Date:  2015-12-30       Impact factor: 9.261

9.  CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+ Pools.

Authors:  Jeffrey P Chmielewski; Sarah C Bowlby; Frances B Wheeler; Lihong Shi; Guangchao Sui; Amanda L Davis; Timothy D Howard; Ralph B D'Agostino; Lance D Miller; S Joseph Sirintrapun; Scott D Cramer; Steven J Kridel
Journal:  Mol Cancer Res       Date:  2018-08-03       Impact factor: 5.852

Review 10.  The complex landscape of pancreatic cancer metabolism.

Authors:  Cristovão Marques Sousa; Alec C Kimmelman
Journal:  Carcinogenesis       Date:  2014-04-17       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.